![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1235, 2000-01, pp. : 13-13
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Should Australia introduce lamivudine for chronic hep B?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 270, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Hepatitis B vaccination: to B or not to B?
Inpharma, Vol. 1, Iss. 1237, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Is prophylactic paroxetine the best tactic for depression with IFN- -2b?
Inpharma, Vol. 1, Iss. 1300, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Addition of ketoprofen to IFN- -2b beneficial in hepatitis C?
Inpharma, Vol. 1, Iss. 1231, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Prednisolone priming beneficial in chronic hepatitis B?
Inpharma, Vol. 1, Iss. 1255, 2000-01 ,pp. :